Assyro AI

Orange Book product · Brand (NDA)

CYKLX

ARTICAINE HYDROCHLORIDE

Brand (NDA)NDA 218643DISCN THEA PHARMA

At a glance

Aug 15, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

3

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 15, 2025

    10 mo ago

  2. Today

  3. Exclusivity ends · NP

    New product exclusivity (3 years)

    Aug 15, 2028

    in 2 yr 2 mo

  4. Patent 11096922 expires

    Listed drug product patent expiration.

    Mar 27, 2039

    in 12 yr 11 mo

  5. Patent 11826347 expires

    Listed drug product patent expiration.

    Mar 27, 2039

    in 12 yr 11 mo

  6. Patent 12403126 expires

    Listed drug product patent expiration.

    Mar 27, 2039

    in 12 yr 11 mo

Pharmaceutical detail

Active ingredient

ARTICAINE HYDROCHLORIDE

Strength

EQ 8% BASE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

TE code

Not listed

Application

NDA 218643

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

  • NPNew product exclusivity (3 years)

    Aug 15, 2028

    in 2 yr 2 mo

Listed patents (3)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11096922Mar 27, 2039in 12 yr 11 mo
ProductU-4423
11826347Mar 27, 2039in 12 yr 11 mo
ProductU-4423
12403126Mar 27, 2039in 12 yr 11 mo
ProductU-4422
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.